First-line Treatment with Ribociclib plus Endocrine Therapy for Premenopausal Women with Hormone-receptor-positive Advanced Breast Cancer: A Cost-effectiveness Analysis
Xiaoting Huang, Shen Lin, Xin Rao, Dayong Zeng, Hang Wang, Xiuhua Weng, Pinfang Huang
Topics & Concepts
MedicineBreast cancerCost effectivenessOncologyEndocrine systemInternal medicineCancerGynecologyHormoneRisk analysis (engineering)Advanced Breast Cancer TherapiesBreast Cancer Treatment StudiesHER2/EGFR in Cancer Research